Business

UK and US Patents Granted for LiquiBand® Exceed

UK and US Patents Granted for LiquiBand® Exceed.

articleAdvanced Medical Solutions Group PlcAugust 4, 20205/company/advanced-medical-solutions-group-plc/news/uk-and-us-patents-granted-for-liquibandr-exceed
UK and US Patents Granted for LiquiBand® Exceed

About this update from Advanced Medical Solutions Group Plc

[{"type":"text","content":"\n \n \n RNS Number : 0054V\n Advanced Medical Solutions Grp PLC\n 04 August 2020\n  \n \n \n \n 04 August 2020\n \n  \n \n Advanced Medical Solutions Group plc\n \n \n (\"AMS\" or the \"Group\")\n \n \n  \n \n \n UK and US Patents Granted for LiquiBand® Exceed\n \n \n  \n \n \n  \n \n \n Winsford, UK: \n Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, today announces that it has been granted UK and US patents for the LiquiBand® Exceed range, providing protection\n until 2034. \n \n \n  \n \n \n The design of the applicator, tip and the raw materials used to manufacture the device has allowed it to be distinguished as a novel, patentable technology. These patents provide long-term protection on a core growth driver for the global LiquiBand®\n  \n portfolio, covering 30-35% of the current product range. \n \n \n  \n \n \n In addition, the UK patent will provide an additional tax benefit to the Group via the UK patent box scheme that is expected to reduce the effective tax rate for the Group by between 1% and 2% throughout the patent life.\n \n \n  \n \n \n Chris Meredith, Chief Executive Officer of AMS, commented:\n \"With end sales demand for LiquiBand® in the US showing early signs of recovery demonstrated by market share gains in the first quarter of 2020, these newly granted patents will further strengthen and protect growth in our core markets. They also highlight AMS's continued ability to design, develop and sell innovative, patentable technology.\"\n \n \n  \n \n \n - End -\n \n \n  \n \n \n  \n \n \n  \n \n \n  \n \n \n For further information, please contact:\n \n \n  \n \n \n \n \n \n Advanced Medical Solutions Group plc\n \n \n \n \n Tel: +44 (0) 1606 545508\n \n \n \n \n \n \n Chris Meredith, Chief Executive Officer\n \n \n Eddie Johnson, Chief Financial Officer\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Consilium Strategic Communications\n \n \n \n \n Tel: +44 (0) 20 3709 5700\n \n \n \n \n \n \n Mary-Jane Elliott / Matthew Neal \n / Olivia Manser\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Investec Bank PLC (NOMAD & Broker)\n \n \n \n \n Tel: +44 (0) 20 7597 5970\n \n \n \n \n \n \n Daniel A...

More updates from Advanced Medical Solutions Group Plc